Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement
- 15 May 1993
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 341 (8855), 1227-1232
- https://doi.org/10.1016/0140-6736(93)91143-a
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study GroupTransfusion, 1992
- Red cell transfusions in total knee and total hip replacement surgeryTransfusion, 1991
- Collection and Transfusion of Blood in the United States, 1982–1988New England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986